This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The global osteoarthritis market revenues are forecasted to touch US$12.14 billion in 2026, growing at a CAGR of 9.84% for the period spanning 2022 to 2026.
Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth. However, growth of the industry would be challenged by associated business risk, patient health-associated risk and stringent regulations. A few notable trends include growth in pharmaceutical R&D expenditures, progressing product pipeline, advancement in osteoarthritis treatments and growth in online pharmaceutical sales.
The global osteoarthritis market by treatment type is segmented into categories i.e. IA Injections (corticosteroids and HA) and Drugs (NSAIDs & Analgesics). Among them, IA injections held the largest share of the industry revenues due to growth in prevalence of joint disorders across the world.
The fastest growing regional market is North America. The growth was supported by growth in geriatric population, surge in HA injections demand, rise in sports injuries and development in e-commerce industry. The U.S. is the largest market and is already well-penetrated at developed market levels.
Scope of the report
- The report provides a comprehensive analysis of the global osteoarthritis market, segmented into IA Injections and Drugs (Analgesics and NSAIDs).
- The major regional markets (North America, Europe and Asia-Pacific) have been analysed along with country coverage of US.
- The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
- The company profiles of leading players i.e. Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline Plc, Pfizer Inc. and Sanofi S.A. are also presented in detail.
Key Target Audience
- Osteoarthritis Therapeutics Manufacturers
- Ingredient Suppliers
- End Users
- Consulting Firms
- Investment Banks
- Government Bodies & Regulating Authorities
Please note: 10% free customization equates to up to 3 hours of analyst time.
Table of Contents
Companies Mentioned
- Sanofi S.A.
- Pfizer Inc.
- Bayer AG
- Novartis AG
- Johnson & Johnson
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 95 |
| Published | May 2022 |
| Forecast Period | 2022 - 2026 |
| Estimated Market Value ( USD | $ 8340 Billion |
| Forecasted Market Value ( USD | $ 12140 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 5 |
